ClinicalTrials.gov · NCT07354620 · Active, not recruiting
A Pilot Study on Reverse Aging (The REVERSE Study)
Registry record
NCT07354620 on ClinicalTrials.gov. The registry's last update to this record was 21 January 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered A Pilot Study on Reverse Aging (The REVERSE Study) Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor The Christ Hospital Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Rapamycin (Tablets); Prolon diet Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Biological Age from Baseline to End of Study based on Tru Diagnostic Tru Age OMICm Age test results. Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Active, not recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-01-21. Checked
Check history: NCT07354620 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: The Christ Hospital
- Phase: Early Phase 1
- Status: Active, not recruiting
- Intervention: Rapamycin (Tablets); Prolon diet
- Primary outcome: Change in Biological Age from Baseline to End of Study based on Tru Diagnostic Tru Age OMICm Age test results.
- Countries: United States
- Start: 15 February 2025
- Completion (estimated): May 2026
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.
Related modality